• 

  Professor Mirim Jin of Gachon University College of Medicine Selected for the Ministry of Science and ICT's 2026 First-Round Bio and Medical Technology Development New Project

  July 08, 2026

  Professor Mirim Jin has been selected for a new research and development project in the "Future Infectious Disease Technology Development" category of the "2026 Bio and Medical Technology Development Program," organized by the Ministry of Science and ICT and administered by the National Research Foundation of Korea (NRF).This program is a national R&D initiative aimed at securing core source t...

  READ MORE >
• 

  Selected for the 2022 First-Round Health and Medical Technology R&D Program

  July 07, 2026

  Our company has been selected for a research and development project under the "Unmet Therapeutics Challenge Technology Development" category of the "Infectious Disease Prevention and Treatment Technology Development Program," organized by the Ministry of Health and Welfare and administered by the Korea Health Industry Development Institute (KHIDI). This program is part of the "2022 First-Round He...

  READ MORE >
• 

  Professor Mirim Jin of Gachon University College of Medicine was invited as a speaker to the 2024 Biomolecular Horizons Congress

  September 27, 2024

  Professor Mirim Jin of Gachon University College of Medicine delivered a lecture on the topic "Highly secreted tryptophanyl-tRNA synthetase as a theranostic target for hypercytokinemic severe sepsis" at the 2024 Biomolecular Horizons Congress.The BMH 2024 Congress was held from September 22 to 26 in Melbourne, Australia, where experts gathered to discuss the latest trends in biomolecular rese...

  READ MORE >
• 

  PCMO and MirimGENE begin development of ‘WARS1’ targeted Tuberculosis treatment

  July 17, 2024

  PCMO (Public CDMO for Microbial-based Vaccines, Director Min Cho) and MirimGENE Co., Ltd. (CEO Mirim Jin) are co-developing a ' Recombinant protein therapy for Tuberculosis' based on the innovative drug platform targeting WARS1(Tryptophanyl- tRNA synthetase 1) and announced this on July 16.   source: https://www.yakup.com/news/index.html?mode=view&pmode=&cat=&cat2=&...

  READ MORE >
• 

  Professor Mirim Jin of Gachon University College of Medicine won the 34th Science and Technology Outstanding Paper Award in 2024

  July 16, 2024

  가천대 의과대학 진미림 교수가 제2회 세계 한인 과학기술인 대회에서 한국과학기술단체총연합회가 수여하는 보건의료분야 과학기술 우수논문상을 수상했다.  진미림 교수는 한국응용약물학회에서 발간하는 Biomolecules & Therapeutics 저널에 게재한 “Phytochemicals That Act on Synaptic Plasticit...

  READ MORE >
• 

  “㈜미림진, ㈜보령과 혁신신약 개발분야 업무 협약(MOU) 체결” / MirimGENE and BORYUNG signed an MOU in the field for innovative new drug development

  March 13, 2024

  ㈜미림진(대표 진미림)은 ㈜보령(대표 장두현)과 혁신신약 개발 분야 업무제휴 협약(MOU)을 체결했다고 13일 밝혔다.   ㈜미림진과 ㈜보령은 이번 전략적 업무 제휴를 바탕으로 난치성 면역 질환 혁신 신약과 제약산업 경쟁력 강화를 위해 양사의 협력을 도모할 예정이다.    &...

  READ MORE >